Eran Bendavid

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi HIV and Africa's elderly: the problems and possibilities
    Eran Bendavid
    Division of General Medical Disciplines, Stanford University, Stanford, California 94305, USA
    AIDS 26:S85-91. 2012
  2. ncbi HIV development assistance and adult mortality in Africa
    Eran Bendavid
    Division of General Medical Disciplines, Center for Health Policy, Stanford University, Stanford, California 94305, USA
    JAMA 307:2060-7. 2012
  3. ncbi United States aid policy and induced abortion in sub-Saharan Africa
    Eran Bendavid
    Department of Medicine, Stanford University, 251 Campus Drive, Stanford, CA 94305, United States of America
    Bull World Health Organ 89:873-880C. 2011
  4. ncbi Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countries
    Katherine A Muldoon
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada
    Global Health 7:42. 2011
  5. ncbi Comparative analysis of old-age mortality estimations in Africa
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, California, United States of America
    PLoS ONE 6:e26607. 2011
  6. ncbi The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, CA 94305, USA
    BMJ 341:c6218. 2010
  7. ncbi Comparative effectiveness of HIV testing and treatment in highly endemic regions
    Eran Bendavid
    Division of General Internal Medicine, Center for Health Policy, Department of Management Science and Engineering, Stanford University, 117 Encina Commons, Stanford, CA 94305 8526, USA
    Arch Intern Med 170:1347-54. 2010
  8. ncbi Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, USA
    AIDS 25:211-20. 2011
  9. ncbi Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis
    Eran Bendavid
    Department of Medicine, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA 94305, USA
    J Acquir Immune Defic Syndr 52:106-13. 2009
  10. ncbi The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes
    Eran Bendavid
    Stanford University, Stanford, California, USA
    Ann Intern Med 150:688-95. 2009

Detail Information

Publications24

  1. ncbi HIV and Africa's elderly: the problems and possibilities
    Eran Bendavid
    Division of General Medical Disciplines, Stanford University, Stanford, California 94305, USA
    AIDS 26:S85-91. 2012
    ....
  2. ncbi HIV development assistance and adult mortality in Africa
    Eran Bendavid
    Division of General Medical Disciplines, Center for Health Policy, Stanford University, Stanford, California 94305, USA
    JAMA 307:2060-7. 2012
    ..The initiative's effect on all-cause adult mortality is unknown...
  3. ncbi United States aid policy and induced abortion in sub-Saharan Africa
    Eran Bendavid
    Department of Medicine, Stanford University, 251 Campus Drive, Stanford, CA 94305, United States of America
    Bull World Health Organ 89:873-880C. 2011
    ..To determine whether the Mexico City Policy, a United States government policy that prohibits funding to nongovernmental organizations performing or promoting abortion, was associated with the induced abortion rate in sub-Saharan Africa...
  4. ncbi Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countries
    Katherine A Muldoon
    British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada
    Global Health 7:42. 2011
    ..abstract:..
  5. ncbi Comparative analysis of old-age mortality estimations in Africa
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, California, United States of America
    PLoS ONE 6:e26607. 2011
    ..These estimates are important for social planning and demographic projections. We provide direct estimations of older-age mortality using survey data...
  6. ncbi The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, CA 94305, USA
    BMJ 341:c6218. 2010
    ..To determine the association of reductions in price of antiretroviral drugs and foreign assistance for HIV with coverage of antiretroviral treatment...
  7. ncbi Comparative effectiveness of HIV testing and treatment in highly endemic regions
    Eran Bendavid
    Division of General Internal Medicine, Center for Health Policy, Department of Management Science and Engineering, Stanford University, 117 Encina Commons, Stanford, CA 94305 8526, USA
    Arch Intern Med 170:1347-54. 2010
    ..Universal testing and treatment holds promise for reducing the burden of human immunodeficiency virus (HIV) in sub-Saharan Africa, but linkage from testing to treatment sites and retention in care are inadequate...
  8. ncbi Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis
    Eran Bendavid
    Division of General Internal Medicine, Stanford University, Stanford, USA
    AIDS 25:211-20. 2011
    ..the World Health Organization (WHO) recently changed its first-line antiretroviral treatment guidelines in resource-limited settings. The cost-effectiveness of the new guidelines is unknown...
  9. ncbi Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis
    Eran Bendavid
    Department of Medicine, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA 94305, USA
    J Acquir Immune Defic Syndr 52:106-13. 2009
    ..The effectiveness and cost-effectiveness of increasing the number of antiretroviral regimens is unknown...
  10. ncbi The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes
    Eran Bendavid
    Stanford University, Stanford, California, USA
    Ann Intern Med 150:688-95. 2009
    ..Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has been the most ambitious initiative to address the global HIV epidemic. However, the effect of PEPFAR on HIV-related outcomes is unknown...
  11. ncbi Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis
    Eran Bendavid
    Center for Health Policy and the Center for Primary Care and Outcomes Research, School of Medicine, Stanford University, 117 Encina Commons, Stanford, CA 94305, USA
    Arch Intern Med 168:1910-8. 2008
    ..Although the number of infected persons receiving highly active antiretroviral therapy (HAART) in low- and middle-income countries has increased dramatically, optimal disease management is not well defined...
  12. ncbi Complication rates on weekends and weekdays in US hospitals
    Eran Bendavid
    Center for Health Policy, Stanford Medical School, Stanford, Calif 94305, USA
    Am J Med 120:422-8. 2007
    ..Recent studies and anecdotal evidence suggest that patient safety may be compromised on weekends. Our objective was to determine whether rates of complications in hospitals are higher on weekends than on weekdays...
  13. ncbi The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men
    Jessie L Juusola
    Stanford University, California, USA
    Ann Intern Med 156:541-50. 2012
    ..The Centers for Disease Control and Prevention recently provided interim guidance for PrEP in MSM at high risk for HIV. Previous studies did not reach a consistent estimate of its cost-effectiveness...
  14. ncbi The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA
    Jessie L Juusola
    Department of Management Science and Engineering, Stanford University, California, USA
    AIDS 25:1779-87. 2011
    ..We estimated the effectiveness and cost-effectiveness of strategies to identify and treat acute HIV infection in men who have sex with men (MSM) in the USA...
  15. ncbi Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users
    Lauren E Cipriano
    Department of Management Science and Engineering, Stanford University, Stanford, California, USA
    PLoS ONE 7:e45176. 2012
    ..To estimate the cost, effectiveness, and cost effectiveness of HIV and HCV screening of injection drug users (IDUs) in opioid replacement therapy (ORT)...
  16. ncbi Systematic review: the effects of growth hormone on athletic performance
    Hau Liu
    Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Ann Intern Med 148:747-58. 2008
    ..Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood...
  17. ncbi Characteristics of U.S. emergency departments that offer routine human immunodeficiency virus screening
    Laura J Berg
    Stanford Kaiser Emergency Medicine Residency, Stanford, CA, USA
    Acad Emerg Med 19:894-900. 2012
    ....
  18. ncbi The relationship between HIV testing, stigma, and health service usage
    Sean D Young
    Department of Medicine, Division of Infectious Diseases, UCLA, Los Angeles, CA, USA
    AIDS Care 22:373-80. 2010
    ..To our knowledge, this is the first study to attempt to use observational data on health service usage for assessing stigma and people's attempts to deal with HIV testing stigma...
  19. ncbi Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of life
    Philip M Grant
    Stanford University, Division of Infectious Diseases, Palo Alto, CA 94305 5107, USA
    J Clin Virol 46:305-8. 2009
    ..Raltegravir is a potential treatment option for virologically suppressed HIV-1 infected patients on enfuvirtide with injection site reactions...
  20. ncbi Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
    Clay Bavinger
    Center for Primary Care and Outcomes Research, and Center for Health Policy, Stanford University, Stanford, California, United States of America
    PLoS ONE 8:e59551. 2013
    ..Recent studies suggest certain antiretroviral therapy (ART) drugs are associated with increases in cardiovascular disease...
  21. ncbi Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal?
    Diana M Negoescu
    Department of Management Science and Engineering, Stanford University, CA 94305, USA
    Clin Infect Dis 55:1392-9. 2012
    ..If ART reduces HIV progression at high CD4 counts, immediate ART is preferable for most newly infected individuals <35 years even if ART doubles age- and sex-specific cardiac risk...
  22. ncbi Monitoring of antiretroviral therapy in low-resource settings
    Eran Bendavid
    Lancet 372:288-9; author reply 289. 2008
  23. ncbi Hospital workload and adverse events
    Joel S Weissman
    Institute for Health Policy, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Med Care 45:448-55. 2007
    ..Hospitals are under pressure to increase revenue and lower costs, and at the same time, they face dramatic variation in clinical demand...
  24. ncbi Should U.S. hospitals go 24/7?
    Joel S Weissman
    Am J Med 117:202-3. 2004